Small Vessel Vasculitides

  • Peter Lamprecht
  • Wolfgang L. Gross


Vasculitis of small blood vessels of the skin, i.e. arterioles, capillaries and venules, is found in cutaneous leukocytoclastic vasculitis (CLA) as well as in systemic vasculitides. CLA is restricted to the skin, whereas several systemic vasculitides are characterized by an involvement of — predominantly — small vessels affecting various organs including the skin


Systemic Vasculitis Churg Strauss Syndrome Granulomatous Lesion Small Vessel Vasculitis Rheumatoid Vasculitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Austin HA 3d, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314: 614–619PubMedCrossRefGoogle Scholar
  2. Ballieux BE, Hiemstra PS, Klar-Mohamad N, Hagen EC, van Es LA, van der Woude FJ, Daha MR (1994) Detachment and cytolysis of human endothelial cells by proteinase 3. Eur J Immunol 24: 3211–3215PubMedCrossRefGoogle Scholar
  3. Bergstein J, Leiser J, Andreoli SP (1998) Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 49: 9–14PubMedGoogle Scholar
  4. Boumpas DT, Yamada H, Patronas NJ, Scott D, Klippel JH, Balow JE (1991) Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med 81: 975–984PubMedCrossRefGoogle Scholar
  5. Brons RH, Bakker HI, Van Wijk RT, Van Dijk NW, Muller Kobold AC, Limburg PC, Manson WL, Kallenberg CG, Cohen Tervaert JW (2000) Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener’s granulomatosis? Clin Exp Immunol 119: 566–573PubMedCrossRefGoogle Scholar
  6. Baumert E, Schlesier M, Wolff-Vorbeck G, Peter HH (1992) Alterations in lymphocyte subsets in variable immunodeficiency syndrome. Immun Infekt 20: 73–75PubMedGoogle Scholar
  7. Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA (2000) Subacute bacterial endocarditis with positive C-ANCA and antiproteinase 3 antibodies. Arthritis Rheum 43: 226–231PubMedCrossRefGoogle Scholar
  8. Claudy A (1998) Pathogenesis of leukocytoclastic vasculitis. Eur J Dermatol 8: 75–79PubMedGoogle Scholar
  9. Cockwell P, Brooks CJ, Adu D, Savage COS (1999) Interleukin-8: pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int 55: 852–863PubMedCrossRefGoogle Scholar
  10. Csernok E, Lüdemann J, Gross WL, Bainton DF (1990) Ultrastructural localization of protei-nase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener’s granulomatosis. Am J Pathol 137: 1113–1120PubMedGoogle Scholar
  11. Csernok E, Trabandt A, Müller A, Wang GC, Moosig F, Paulsen J, Schnabel A, Gross WL (1999) Cytokine profiles in Wegner’s granulomatosis. Predominance of type 1 ( Thl) in the granulomatous inflammation. Arthritis Rheum 42: 742–750Google Scholar
  12. Csernok E, Gross WL (2000) Primary vasculitides and vasculitis confined to the skin: clinical features and new pathogenic aspects. Arch Dermatol Res 292: 427–436.PubMedCrossRefGoogle Scholar
  13. Dammacco F, Sansonno D, Han JH, Shyamala V, Cornacchiulo V, Iacobelli AR, Lauletta G, Rizzi R (1994) Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 84: 3336–3343PubMedGoogle Scholar
  14. D’Amico G (1998) Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54: 650–671PubMedCrossRefGoogle Scholar
  15. deGroot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nolle B, Gross WL (1996) Therapy for the maintenance of remission in sixty-five patients with generalized Wegener’s granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 39: 2052–2061Google Scholar
  16. deGroot K, Haubitz M, Haller H (2000) ANCA-assoziierte Vaskulitiden. Neue Konzepte and Strategien in der Therapie. Internist 41: 1112–1119Google Scholar
  17. Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic auto-antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87: 4115–4119PubMedCrossRefGoogle Scholar
  18. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Fosella PV, Pasero G, Bombardieri (1991) Antibodies to hepatits C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 34: 1606–1610Google Scholar
  19. Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R, Liberati AM, Gerli R, Greco F, Moretti A (1993) Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 81: 1132–1136PubMedGoogle Scholar
  20. Fujioka A, Yamamoto T, Takasu H, Kawano K, Masuzawa M, Katsuoka K, Jinno S (1998) The analysis of mRNA expression of cytokines from skin lesions in Churg-Strauss syndrome. J Dermatol 25: 171–177PubMedGoogle Scholar
  21. Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL, Cerundolo V (2000) TAP deficiency syndrome. Clin Exp Immunol 121: 173–178PubMedCrossRefGoogle Scholar
  22. Gause A, Inderrieden DC, Laas R, Arlt AC, Gross WL (2000) Common variable immunodeficiency ( CVID) and inclusion body myositis. Immunobiology 202: 199–203Google Scholar
  23. Gross WL, Csernok E, Schmitt WH (1991) Antineutrophil cytoplasmic autoantibodies: immunobiolgical aspects. Klin Wochenschr 69: 558–566.PubMedCrossRefGoogle Scholar
  24. Gross WL (1997) Immunopathogenesis of vasculitis. In: Klippel JH, Dieppe PA (eds) Rheumatology. 2nd ed. Mosby, London, chapter 7. 19, p. 1–8Google Scholar
  25. Gross WL, Trabandt A, Reinhold-Keller E (2000) Diagnosis and evaluation of vasculitis. Rheumatology 39: 245–252PubMedCrossRefGoogle Scholar
  26. Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Ludemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ (1998) Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 53: 743–753Google Scholar
  27. Hautmann G, Campanile G, Lotti TM (1999) The many faces of cutaneous vasculitis. Clin Dermatol 17: 515–531PubMedCrossRefGoogle Scholar
  28. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488–498PubMedGoogle Scholar
  29. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Michel BA, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (19990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 33: 1065–1067Google Scholar
  30. Jayne DR, Chapel H, Adu D, Misbah S, O’Donoghue D, Scott D, Lockwood CM (2000a) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93: 433–439PubMedCrossRefGoogle Scholar
  31. Jayne DR, Gaskin G for the European Vasculitis Study Group (2000b) Randomized trial of cyclophosphamide versus azathioprine during remission in ANCA associated systemic vasculitis (CYCAZAREM). Clin Exp Immunol 120 (Supp1.1): 74Google Scholar
  32. Jenne DE, Tschopp J, Lüdemann J, Utech B, Gross WL (1990) Wegener’s autoantigen decoded. Nature 346: 520.PubMedCrossRefGoogle Scholar
  33. Jennette JC (1991) Antineutrophil cytoplasmic autoantibody associated diseases: a pathologist’s perspective. Am J Kidney Dis 18: 164–170PubMedGoogle Scholar
  34. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McCluskey RT, Sinico A, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187–192Google Scholar
  35. Jennette JC, Falk R. (1997) Small-vessel vasculitis. N Engl J Med 337: 1512–1523PubMedCrossRefGoogle Scholar
  36. Kallenberg CG, Cohen Tervaert JW (2000) New treatments of ANCA-associated vasculitis. Sarcoidosis Vasc Diffuse Lung Dis 17: 125–129PubMedGoogle Scholar
  37. Kiene M, Csernok E, Müller A, Metzler C, Trabandt A, Gross WL (2001) Elevated IL-4 and IL-13 production by T-cell lines in Churg-Strauss syndrome. Arthritis Rheum 44: 469–473PubMedCrossRefGoogle Scholar
  38. Langford CA, Talar-Williams C, Sneller MC. Use of methotrexate and glucocorticoids in the treatment of Wegener’s granulomatosis. Long-term renal outcome in patients with glomerulonephritis. Arthritis Rheum 43: 1836–1840Google Scholar
  39. Lamprecht P, Gadola S, Schnabel A, Gross WL (1998) ANCA, infectious endocarditis, glomerulonephritis and cryoglobulinemic vasculitis. Clin Nephrol 49: 389–390PubMedGoogle Scholar
  40. Lamprecht P, Gause A, Gross WL (1999). Cryoglobulinemic vasculitis. Arthritis Rheum 42: 2507–2516PubMedCrossRefGoogle Scholar
  41. Lamprecht P, Trabandt A, Gross WL (2000) Clinical and immunological aspects of Wegener’s granulomatosis ( WG) and other syndromes resembling WG. Isr Med Assoc J 2: 621–626Google Scholar
  42. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 63: 65–81Google Scholar
  43. Ludviksson BJ, Sneller MC, Chua KS, Talar-Williams C, Langford CA, Ehrhardt RO, Fauci AS, Strober W (1998) Active Wegener’s granulomatosis is associated with HLA-DR+CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 160: 3602–3609PubMedGoogle Scholar
  44. Metzler C, Loew-Friedrich I, Reinhold-Keller E, Fink C, Gross WL (1999) Maintenance of remission with leflunomide in Wegener’s granulomatosis. Arthritis Rheum 42 (Supp1.1): S315Google Scholar
  45. Metzler C, Tatsis E, Gause A, Gross WL (2000) Long-term treatment of Churg-Strauss syndrome with interferon-a. Arthritis Rheum 43 (Suppl): S369Google Scholar
  46. Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, Baycal C, Lambert J, Bigliardi P, Willemsen M, Jones M, Buechner S, Colonna M, Gross WL, Cerundolo V (1999) Association of a syndrome resembling Wegener’s granulomatosis with low surface expression of HLA class-I molecules. Lancet 354: 1598–1603PubMedCrossRefGoogle Scholar
  47. Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross WL (1998) Elevated procalcitonin levels in active Wegener’s granulomatosis. J Rheumatol 25: 1531–1533PubMedGoogle Scholar
  48. Müller A., Trabandt A, Glöckner-Hofmann K, Seitzer U, Csernok E, Schönermarck U, Feller AC, Gross WL (2000) Localized Wegener’s granulomatosis: predominance of CD26 and IFN-y expression. J Path 192: 113–120PubMedCrossRefGoogle Scholar
  49. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP (1994) Antineutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIla. J Immunol 153: 1231–1280Google Scholar
  50. Powell FC, Schroeter AL, Su WPD, Perry HO (1985) Pyoderma gangrenosum: A review of 86 patients. Q J Med 55: 173–82PubMedGoogle Scholar
  51. Radford DJ, Savage CO, Nash GB (2000) Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion. Arthritis Rheum 43: 1337–1345PubMedCrossRefGoogle Scholar
  52. Rao JK, Allen NB, Pincus T (1998) Limitations of the 1990 American College of Rheumatol- ogy classification criteria in the diagnosis of vasculitis. Ann Intern Med 129: 345–352Google Scholar
  53. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL (1994) Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener’s granulomatosis. Arthritis Rheum 37: 919–924PubMedCrossRefGoogle Scholar
  54. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, Heller M, Gross WL (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43: 1021–1032PubMedCrossRefGoogle Scholar
  55. Sais G, Vidaller A, Servitje O, Jucgla A, Peyri J (1996) Leukocytoclastic vasculitis and common variable immunodeficiency: successful treatment with intravenous immune globulin. J Allergy Clin Immunol 98: 232–233.PubMedCrossRefGoogle Scholar
  56. Savage COS, Harper L, Adu D (1997) Primary systemic vasculitis. Lancet 349: 553–558 Schmitt WH, Gross WL (1998) Vasculitis in the seriously ill patient: diagnostic approaches and therapeutic options in ANCA-associated vasculitis. Kidney Int Suppl 64: S39–44Google Scholar
  57. Schönermarck U, Lamprecht P, Csernok E, Gross WL (2001) Prevalence and spectrum of rheumatic diseases associated with PR3-ANCA and MPO-ANCA. Rheumatology 40: 178–184PubMedCrossRefGoogle Scholar
  58. Schur PH (1993) Clinical features of SLE. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB (eds) Textbook of Rheumatology, Volume 2. WB Saunders Company, Philadelphia London Toronto Montreal Sydney Tokyo, pp 1017–1042Google Scholar
  59. Scott DG, Bacon PA (1984) Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 76: 377–384PubMedCrossRefGoogle Scholar
  60. Simpson IJ, Skinner MA, Geursen A, Peake JS, Abbott WG, Fraser JD, Lockwood CM, Tan PLJ (1995) Peripheral blood T lymphocytes in systemic vasculitis. Clin Exp Immunol 101: 220–226PubMedGoogle Scholar
  61. Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM (1996) Trimethoprimsulfmethoxazole ( Co-trimoxazole) for the prevention of relapses in Wegener’s granulomatosis. N Engl J Med 335: 16–20Google Scholar
  62. Stone JH for the WGET investigators (2000) Etanercept in Wegner’s granulomatosis (WG): Design of a randomized, multi-center trial. Clin Exp Immunol 120 (Suppl 1): 72Google Scholar
  63. Tatsis E, Schnabel A, Gross WL (1998) Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 129: 370–374PubMedGoogle Scholar
  64. Tsukadaira A, Okubo Y, Kitano K, Horie S, Momose T, Takashi S, Suzuki J, Isobe M, Sekiguchi M (1999) Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc 20: 39–44PubMedCrossRefGoogle Scholar
  65. Wegener F (1939) Über eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Pathol Anat Allg Pathol 102: 36–68Google Scholar
  66. Wei G, Yano S, Kuroiwa T, Hiromura K, Maezawa A (1997) Hepatitis C virus (HCV)-induced IgG-IgM rheumatoid factor ( RF) complex may be the main causal factor for cold-dependent activation of complement in patients with rheumatic disease. Clin Exp Immunol 107: 83–88.Google Scholar

Copyright information

© Springer-Verlag Wien 2001

Authors and Affiliations

  • Peter Lamprecht
  • Wolfgang L. Gross

There are no affiliations available

Personalised recommendations